Hasini Jayatilaka: How cancer cells communicate -- and how we can slow them down
Hasini Đajatilaka (Hasini Jayatilaka): Kako ćelije raka komuniciraju - i kako da ih usporimo
Hasini Jayatilaka discovered a novel mechanism that causes cancer cells to break away from tumors and metastasize. Full bio
Double-click the English transcript below to play the video.
that takes an enormous emotional toll.
koja uzima ogroman emotivni danak.
but the patient's loved ones, as well.
već i njihovim voljenima.
has been fighting for centuries.
will develop cancer in their lifetime.
oboli od raka u toku života.
to the disease due to metastases.
zbog metastaza.
from a primary site to a distal site,
sa primarnog na distalno područje,
or the lymphatic system.
with breast cancer
because she has a mass on her breast.
jer ima masu na dojci.
because it spreads
jer se bolest proširila
lymph nodes, brain, bone,
limfne čvorove, mozak, kosti,
or untreatable.
for several years now.
već nekoliko godina.
and I discovered recently
to communicate with each other
međusobno da komuniciraju
in the tumor microenvironment.
u mikrosredini tumora.
through two signaling molecules
dva signalizirajuća molekula
the signal is enhanced,
to move away faster from the primary site
brže putuju sa primarne lokacije
using a drug cocktail that we developed,
koristeći koktel lekova koji smo razvili,
between cancer cells
između kancerogenih ćelija
this all began for me in 2010,
kada je sve ovo započelo,
in Dr Danny Wirtz's lab
u laboratoriji Dr Denija Virca
naive, Sri Lankan girl,
naivna Šrilankanka,
to look at how cancer cells move
da posmatram kretanje kancerogenih ćelija
are exposed to in our bodies.
izložene u našim telima.
on 2D, flat, plastic dishes
ravnim, plastičnim posudama,
are exposed to in our bodies.
izložene u našim telima.
aren't stuck onto plastic dishes.
nisu zalepljene na plastične posude.
that I attended a seminar
from Princeton University,
sa Prinston Univerziteta,
communicate with each other,
međusobno komuniciraju,
and perform a specific action.
i izvode izvesne radnje.
went off in my head, and I thought,
i pomislila sam,
in my cancer cells every day,
kancera svakodnevno,
are able to communicate with each other
mogu međusobno da komuniciraju
in the tumor microenvironment.
u mikrosredini tumora.
this hypothesis.
dokazivanjem ove hipoteze.
with my crazy ideas.
students, graduate students,
diplomirane studente,
and multiple disciplines
as a sophomore in college.
na drugoj godini koledža.
experiments together
eksperimenata zajedno
and perspectives,
i perspektiva,
communicate with each other and move,
komuniciraju međusobno i kako se kreću,
as the Hasini effect.
kao Hasini efekat.
to block this signaling pathway
da blokiramo ovu signalnu putanju
the spread of cancer.
animal models.
životinjskim modelima.
consisting of tocilizumab,
koji se sastoji od tocilizumaba,
rheumatoid arthritis,
reumatoidnog artritisa,
in clinical trials against breast cancer.
klinički ispituje protiv kancera dojke.
was that this cocktail of drugs
da ovaj koktel lekova
FDA-approved therapeutics
FDA odobrena terapija
of tumor growth.
proizvodom rasta tumora.
the tumor from growing,
da zaustavimo rast tumora,
that this is not true.
came up with the drug cocktail
osmislili koktel lekova
not by targeting tumor growth,
ne ciljajući rast tumora,
mechanisms that govern it,
kojim se upravlja,
of the Hasini effect.
in "Nature Communications,"
"Komunikacijama prirode".
response from around the world.
brojnim odgovorima sa raznih strana sveta.
this sort of response.
predvideti ovakav odgovor.
for the positive response that I received,
za pozitivne odgovore koje sam primila,
affected by this terrible disease.
koji su pogođeni ovom užasnom bolešću.
I've encountered with the Hasini effect,
na koji sam naišla sa Hasini efektom,
that I was fortunate enough to work with.
sa kojima sam imala sreće da sarađujem.
through their hard work and dedication.
kroz naporan rad i posvećenost.
and the postdoctoral fellows,
who taught me new techniques
koji su me naučili novim tehnikama
da ostanem na pravom putu.
and my Obi-Wan Kenobis,
i moji Obii Van Kenobii,
making this work into what it is today.
da ovaj rad postane ono što jeste.
on our ambitious endeavors.
od naših ambicioznih nastojanja.
we could have asked for.
study metastasis.
da mi pomogne u izučavanju metastaza.
I wouldn't be here.
ne bih bila ovde.
to develop combination therapies
da razvijemo kombinovane terapije
tumor growth and metastases.
rast tumora i metastaze.
new anticancer therapeutics,
drug resistance.
i smanjimo otpornost na lekove.
groundbreaking systems
of better human clinical trials.
boljih kliničkih ispitivanja na ljudima.
talking to you today --
govorim pred vama danas -
at the back of a seminar
u zadnjim redovima na seminaru
I am on this incredible journey
na neverovatnom putovanju
that I am extremely passionate about,
za koji posedujem ogromnu strast,
my curiosity on a daily basis.
moju radoznalost.
my favorite part of all of this --
moj omiljeni deo svega ovog je -
talking to you, today --
i govorim pred vama, danas -
with a diverse group of people,
sa raznolikom grupom ljudi,
better and just so much more fun.
boljim i zabavnijim.
superhuman power.
is that it's not unique to me.
and spread their wrath.
i šire svoju srdžbu.
that has produced incredible discoveries
koja je stvorila neverovatna otkrića
that we can all turn to
kojoj se svi možemo okrenuti
something bigger than ourselves,
nešto veće od nas samih,
the world a better place.
that I turn to, to help me fight cancer.
da mi pomogne da pobedim rak.
that with the right collaborations,
ABOUT THE SPEAKER
Hasini Jayatilaka - Cancer fighterHasini Jayatilaka discovered a novel mechanism that causes cancer cells to break away from tumors and metastasize.
Why you should listen
Hasini Jayatilaka is postdoctoral fellow at Stanford University focused on elucidating mechanisms that govern relapse in childhood cancers, particularly B-cell precursor acute lymphoblastic leukemia (BCP-ALL) and neuroblastoma.
BCP-ALL is a common childhood malignancy that has seen dramatic improvements in survival using current treatment regimens. However, relapse is the most frequent cause of cancer-related death among children with BCP-ALL. Jayatilaka is studying the activation of pro-survival and drug resistance mechanisms in a subset of the BCP-ALL population that allow tumor cells to persist following treatment and cause relapse.
Jayatilaka is currently conducting research on understanding the complex pathways that govern metastasis, the spread of cancer, which is responsible for 90% of cancer related deaths. She recently discovered a new signaling pathway that controls metastasis and showed that by blocking the pathway, the spread of cancer can be slowed down.
Jayatilaka grew up in Sri Lanka and pursued her BS and PhD in Chemical and Bimolecular Engineering at Johns Hopkins University.
Hasini Jayatilaka | Speaker | TED.com